Get the Stockscreener App
2.90
0.00%
0.00
After Hours:
2.95
0.05
+1.72%
Adial Pharmaceuticals Inc stock is traded at $2.90, with a volume of 37,475.
It is up +0.00% in the last 24 hours and up +31.22% over the past month.
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
See More
Previous Close:
$2.90
Open:
$2.93
24h Volume:
37,475
Relative Volume:
0.08
Market Cap:
$6.35M
Revenue:
-
Net Income/Loss:
$-7.77M
P/E Ratio:
-0.2928
EPS:
-9.9046
Net Cash Flow:
$-6.52M
1W Performance:
+11.97%
1M Performance:
+31.22%
6M Performance:
-52.94%
1Y Performance:
-64.52%
1-Day Range:
$2.5701
$2.95
1-Week Range:
$2.525
$2.95
52-Week Range:
$1.31
$18.90
Adial Pharmaceuticals Inc Stock (ADIL) Company Profile
Name
Adial Pharmaceuticals Inc
Sector
Industry
Phone
434-422-9800
Address
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Compare ADIL vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADIL
Adial Pharmaceuticals Inc
|
2.90 | 5.60M | 0 | -7.77M | -6.52M | -9.9046 |
VRTX
Vertex Pharmaceuticals Inc
|
529.59 | 126.07B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
649.81 | 65.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
916.80 | 57.70B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
313.04 | 40.19B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
189.99 | 39.82B | 742.00K | -1.37B | -1.07B | -7.0731 |
Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-14-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-30-18 | Initiated | Maxim Group | Buy |
| Oct-11-18 | Initiated | Dawson James | Buy |
Adial Pharmaceuticals Inc Stock (ADIL) Latest News
Coastlands Group takes 14.22% position in Adial Pharmaceuticals (ADIL) - Stock Titan
Enterprise value to EBIT forward of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView
Coastlands Capital LP acquires $65,000 in Adial Pharmaceuticals - Investing.com
Form 4 Adial Pharmaceuticals Inc For: 1 July By Investing.com - Investing.com Canada
Adial Pharmaceuticals (ADIL) holder Coastlands Capital adds 25,000 shares - Stock Titan
Enterprise value to revenue forward of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView
Adial Pharmaceuticals (ADIL) Gains 1.17% as Shares Approach Key Resistance LevelMFI Oversold - dars.gov.et
Coastlands Capital details ADIAL Pharmaceuticals (ADIL) stock and warrant stake - Stock Titan
Insider Conviction: Why Coastlands Capital is Buying Adial Pharmaceuticals Ahead of a Pivotal Phase 3 - Kavout | AI
ADIL stock eyes best day in over 5 years — major pipeline overhaul and $64M raise fuel rally - MSN
Adial Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:ADIL) - TradingView
ADIL Forecast — Price Target — Prediction for 2027 - TradingView
Coastlands files 9.98% holding in Adial Pharmaceuticals (ADIL) - Stock Titan
ADIL Stock Eyes Best Day In Over 5 Years — Major Pipeline Overhaul And $64M Raise Fuel Rally - Stocktwits
Adial Pharmaceuticals Inc (ADIL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Net current asset value per share of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView
Adial Pharmaceuticals Inc (ADIL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Adial Pharmaceuticals Inc (ADIL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Adial Pharmaceuticals Inc (ADIL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Adial Pharmaceuticals Inc (ADIL) Institutional Confidence - TradingKey
Adial Pharmaceuticals Inc (ADIL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Adial Pharmaceuticals Inc (ADIL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Adial Pharmaceuticals Inc (ADIL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Adial Pharmaceuticals Inc (ADIL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Adial closes $32 million financing, grants stock to new executives By Investing.com - Investing.com South Africa
Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing - The Manila Times
Adial Pharmaceuticals (ADIL) CDO adds RSUs, options and preferred shares after Azora merger - Stock Titan
ADIAL (ADIL) director and CDO Matt Davidson listed in Form 3 filing - Stock Titan
Adial Pharmaceuticals (NASDAQ: ADIL) director buys 36,378 pre-funded warrants - Stock Titan
ADIAL (ADIL) director Wendy Young files initial insider Form 3 statement - Stock Titan
ADIL Initiates Coverage by LUCID CAPITAL MARKETS -- Rating Set t - GuruFocus
ADIL Initiates Coverage by LUCID CAPITAL MARKETS -- Rating Set to Buy - GuruFocus
Lucid Capital Markets initiates Adial Pharmaceuticals stock with buy rating on colitis drug potential - Investing.com UK
Adial Pharmaceuticals (ADIL) Holds Steady at $2.98 as Consolidation NarrowsIchimoku Kumo Twist - newsline.com
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Adial broadens pipeline with Azora acquisition and up to $64 million financing - The Pharma Letter
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Top Midday Gainers - Moomoo
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Adial Pharmaceuticals (ADIL) Acquires Azora Therapeutics and Sec - GuruFocus
Adial Pharmaceuticals acquires Azora Therapeutics, secures up to $64M financing - MSN
Top movers analysis one hour before the close of the markets on 2026-06-11: top gainers and losers in today's session. - ChartMill
Adial Pharmaceuticals (ADIL) Acquires Azora Therapeutics to Enha - GuruFocus
Adial Pharmaceuticals Announces Acquisition Of Azora Therapeutics And Up To $64 Million Financing - TradingView
Adial Pharmaceuticals, Inc. (ADIL) Stock: Strategic Acquisition Positions Company for Clinical Growth - parameter.io
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Adial Pharmaceuticals Acquires Azora and Raises $26.8M PIPE, With More on Milestones - TradingView
Adial Pharmaceuticals acquires Azora Therapeutics for $32M By Investing.com - Investing.com South Africa
Adial (NASDAQ: ADIL) acquires Azora and lines up up to $64M for UC drug - Stock Titan
Adial Pharmaceuticals Inc Stock (ADIL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):